Literature DB >> 24554972

Coordination of bone morphogenetic protein 2 (BMP2) and aberrant canonical Wnt/β-catenin signaling for heterotopic bone formation in adrenal myelolipoma: A case report.

Yozo Mitsui1, Hiroaki Yasumoto1, Miho Hiraki1, Naoko Arichi1, Noriyoshi Ishikawa2, Yuji Harada2, Riruke Maruyama2, Hiroaki Shiina1.   

Abstract

The precise mechanism of heterotopic ossification caused by several types of tumours is largely unknown. However, recent studies have indicated that bone morphogenetic protein 2 (BMP2) is closely linked to the Wnt/β-catenin signaling pathway in this rare phenomenon of bone formation. We report a rare case of adrenal myelolipoma (ML) in a 27-year-old woman with heterotopic bone formation. Immunohistochemical findings showed BMP2 expression in the cytoplasm of tumour cells, as well as the matrix adjacent to newly developed bone tissue. In addition, β-catenin was prominent in the cytoplasm and nuclei of BMP2-positive tumour cells. To the best of our knowledge, this is the first report of adrenal ML showing heterotopic ossification with accelerated expression of both BMP2 and β-catenin. Our case findings indicate that BMP2 overexpression via aberrant canonical Wnt/β-catenin signaling may contribute to heterotopic bone formation occurring in adrenal ML.

Entities:  

Year:  2014        PMID: 24554972      PMCID: PMC3926924          DOI: 10.5489/cuaj.1610

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN: 1911-6470            Impact factor:   1.862


  11 in total

1.  Adrenal myelolipomas show nonrandom X-chromosome inactivation in hematopoietic elements and fat: support for a clonal origin of myelolipomas.

Authors:  Elena Bishop; John N Eble; Liang Cheng; Mingsheng Wang; Donald R Chase; Attilio Orazi; Dennis P O'Malley
Journal:  Am J Surg Pathol       Date:  2006-07       Impact factor: 6.394

2.  Myelolipoma of the renal sinus. An unusual site for a rare extra- adrenal lesion.

Authors:  M B Amin; S K Tickoo; D Schultz
Journal:  Arch Pathol Lab Med       Date:  1999-07       Impact factor: 5.534

3.  Adrenal myelolipoma with translocation (3;21)(q25;p11).

Authors:  Kong Chao Chang; Pei Ih Chen; Zen Hung Huang; Yung Ming Lin; Pao Lin Kuo
Journal:  Cancer Genet Cytogenet       Date:  2002-04-01

4.  Possible involvement of bone morphogenetic protein 2 in heterotopic ossification in metastatic lesion from urothelial carcinoma of bladder.

Authors:  Yoshinobu Komai; Shinji Morimoto; Kazutaka Saito; Masayasu Urushibara; Kunihiko Sakai; Satoshi Ikeda
Journal:  Int J Urol       Date:  2006-08       Impact factor: 3.369

5.  Oncogenic beta-catenin is required for bone morphogenetic protein 4 expression in human cancer cells.

Authors:  Jung-Sik Kim; Heather Crooks; Tatiana Dracheva; Tagvor G Nishanian; Baljit Singh; Jin Jen; Todd Waldman
Journal:  Cancer Res       Date:  2002-05-15       Impact factor: 12.701

6.  Wnt/β-catenin signaling activates bone morphogenetic protein 2 expression in osteoblasts.

Authors:  Rongrong Zhang; Babatunde O Oyajobi; Stephen E Harris; Di Chen; Christopher Tsao; Hong-Wen Deng; Ming Zhao
Journal:  Bone       Date:  2012-09-29       Impact factor: 4.398

7.  Multiple roles of mesenchymal beta-catenin during murine limb patterning.

Authors:  Theo P Hill; Makoto M Taketo; Walter Birchmeier; Christine Hartmann
Journal:  Development       Date:  2006-02-22       Impact factor: 6.868

Review 8.  Heterotopic ossification in rectal cancer: Rare finding with a novel proposed mechanism.

Authors:  Alan P Kypson; Emilie Morphew; Relief Jones; Marcia R Gottfried; Hilliard F Seigler
Journal:  J Surg Oncol       Date:  2003-02       Impact factor: 3.454

9.  γ-Catenin is overexpressed in acute myeloid leukemia and promotes the stabilization and nuclear localization of β-catenin.

Authors:  R G Morgan; L Pearn; K Liddiard; S L Pumford; A K Burnett; A Tonks; R L Darley
Journal:  Leukemia       Date:  2012-08-03       Impact factor: 11.528

Review 10.  Bone tissue in adrenal myelolipoma: a case report.

Authors:  A Rossi; R Incensati
Journal:  Tumori       Date:  1998 Jan-Feb
View more
  5 in total

Review 1.  Update on Adrenal Tumours in 2017 World Health Organization (WHO) of Endocrine Tumours.

Authors:  Alfred King-Yin Lam
Journal:  Endocr Pathol       Date:  2017-09       Impact factor: 3.943

Review 2.  Conserved signaling pathways underlying heterotopic ossification.

Authors:  Chen Kan; Lijun Chen; Yangyang Hu; Na Ding; Haimei Lu; Yuyun Li; John A Kessler; Lixin Kan
Journal:  Bone       Date:  2017-04-25       Impact factor: 4.398

3.  Case Report: An incidentaloma that catches your eye - adrenal myelolipoma.

Authors:  Rosanna D'Addosio; Joselyn Rojas; Valmore Bermúdez; Flor Ledesma; Kyle Hoedebecke
Journal:  F1000Res       Date:  2017-07-18

Review 4.  Heterotopic ossification of tendon and ligament.

Authors:  Qiang Zhang; Dong Zhou; Haitao Wang; Jun Tan
Journal:  J Cell Mol Med       Date:  2020-04-15       Impact factor: 5.310

5.  Inhibition of IL-17 prevents the progression of traumatic heterotopic ossification.

Authors:  Bing Tu; Bo Yu; Wei Wang; Juehong Li; Feng Yuan; Jing Zhu; Cunyi Fan
Journal:  J Cell Mol Med       Date:  2021-06-29       Impact factor: 5.310

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.